FDA Will Lift Import Alert on Sun Pharma’s Mohahi Facility

Drug GMP Report
A A
The FDA plans to lift an import alert against products from a Sun Pharma facility in Mohali, India.

To View This Article:

Login

Subscribe To Drug GMP Report